Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Novel isocyanate route for Landiolol HCl intermediates. High purity, reduced toxicity, and scalable pharmaceutical manufacturing processes.
Patent CN102190642A reveals a scalable Prins reaction route for high-purity Corey lactone, offering significant cost reduction in prostaglandin manufacturing.
Patent CN108467410B reveals a high-yield route for TAF intermediates using triphenyl phosphite, offering significant cost and time reductions for pharmaceutical manufacturers.
Patent CN112390755B enables mild heteroarylation of amines using visible light. This breakthrough offers cost reduction and supply reliability for pharmaceutical intermediate manufacturing globally.
Patent CN1305460A reveals a novel resolution process using L-pyroglutamic acid for high-purity tetrahydrocarbazole intermediates, offering significant cost and supply chain advantages.
Advanced one-pot synthesis of Lansoprazole via patent CN112707889A. Achieves >99.9% purity and >92% yield with reduced waste, offering a reliable lansoprazole intermediate supplier solution.
Patent CN115894496B reveals a green enzymatic route for Ticagrelor intermediates. Achieve high purity and cost reduction in pharmaceutical manufacturing with scalable supply.
Patent CN101155820A reveals a safe phosphite-based dehalogenation route for valiolamine intermediates, offering significant cost reduction and scalable manufacturing for diabetes drug precursors.
Novel patent CN104592339A offers high-yield steroid intermediate synthesis. Reduces cost and improves supply chain reliability for pharmaceutical manufacturing.
Novel iodination-elimination route avoids DDQ. Ensures 99.5% purity and scalable production for global pharmaceutical supply chains.
Novel progesterone preparation method using copper/TEMPO. High purity, cost-effective, scalable for pharmaceutical intermediates supply chain.
Patent CN107778269A reveals a robust synthesis route for morpholine compounds. This report analyzes cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability.
Patent CN103936813A reveals a green synthetic method for Desonide with higher yield and purity, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
This report analyzes patent CN114380729B for vildagliptin production offering high purity and yield advantages for pharmaceutical supply chains and procurement teams globally.
Patent CN112979648A details a novel Rh-catalyzed C-H activation route for gamma-carbolines. Discover cost-effective manufacturing and scalable supply chain solutions.
Patent CN109516938A reveals improved solubility derivatives. Enhances supply chain reliability and reduces manufacturing complexity for global pharmaceutical partners.
Novel Raney Nickel catalyzed route for ertapenem sodium salt offering high purity and cost efficiency for pharmaceutical supply chains globally.
Patent CN114736144B reveals high-purity docusate calcium synthesis. Offers superior powder form, cost reduction in pharmaceutical manufacturing, and reliable supply chain solutions.
Patent CN102659639B details a cost-effective Leonurine synthesis. High yield, mild conditions, suitable for industrial scale-up.
Novel process for indolizine derivatives via condensation. Offers improved scalability and purity for testosterone 5α-reductase inhibitors.